Table 1.
Non-coding RNAs and mechanisms involved in CCL2 regulation.
| Name | Cancer Type | Target | Up- or down-regulation of CCL2 | Ref. |
|---|---|---|---|---|
| miR-339-5p | OSCC | TSPAN15 | Down | (24) |
| miR-122 | HCC | – | Down | (25) |
| MiR-124 | OC | – | Down | (26) |
| miR-1246 | BC | PRKAR1A, PPP2CB | Up | (27) |
| miR-1, miR-206, miR-31 | LC | OXO3a/VEGF/CCL2 | Up | (28) |
| miR-122 | HCC | C/EBPα | Down | (29) |
| miR-511 | AML | cyclin D1 | Up | (30) |
| MiR-19a | GC | IκB−α | Up | (31) |
| miR-126/miR-126(*) | BC | SDF-1α | Down | (32) |
| miR-16 | BC | IKKα | Down | (33) |
| miR-200c | BC | p65/RelA, JNK2 | Up | (34) |
| LncHOTAIR | CRC | miR-206/CCL2 | Up | (35) |
| Antisense IL-7 | – | NF-κB/MAPK | Up | (36) |
| LncHOTAIR | HCC | – | Up | (37) |